Analyst Research Report Snapshot

Title:

Acura Pharmaceuticals, Inc.

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

11 Jun 2014

Pages:

34

Type:

AcrobatPDF

Companies referenced:

ACUR.OQ

Available for Immediate Download
Summary:

Acura Pharmaceuticals, Inc. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Acura Pharmaceuticals, Inc. required for business and competitor intelligence needs - Intelligence on Acura Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Acura Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Acura Pharmaceuticals (Acura) is a specialty pharmaceutical company that is involved in developing and commercializing tamper-resistant products to that are intended for medication abuse and misuse. The company’s tamper-resistant technologies include AVERSION oxycodone and NEXAFED. In addition, Acura has seven other abuse deterrent products in development: Hydrocodone bitartrate/acetaminophen tablets, Oxycodone HCl/acetaminophen tablets, Hydromorphone tablets, Morphine tablets, Oxymorphone tablets, Tramadol tablets and Methadone tablets. The company primarily operates in the US, where it is headquartered in Palatine, Illinois, and employs around 15 people. The company recorded revenues of $123 thousand in the fiscal year ended December 2013. The company's operating loss was $14,090 thousand in fiscal 2013, as compared to an operating loss of $9,739 thousand in 2012. Its net loss was $13,901 thousand in fiscal 2013, as compared to the net loss of $9,668 thousand in 2012. Reasons to Purchase: - Gain understanding of Acura Pharmaceuticals, Inc. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Acura Pharmaceuticals, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Acura Pharmaceuticals, Inc. your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.